FAS and neoplasm: In addition to regulating target cell lysis in the immune system, Fas signaling also contributes to the establishment of immune privilege and to tumor survival; therefore, the clinical and pharmacological potential of Fas and/or FasL as targets for therapeutic intervention has received considerable attention [19].